v3.23.2
Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net income $ 82,600,000 $ 22,100,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 40,700,000 42,500,000
Amortization of debt discounts and issuance costs 1,200,000 1,500,000
Amortization of deferred commissions costs 38,300,000 30,000,000.0
Asset impairments 600,000 0
Loss on debt modification and extinguishment 2,200,000 0
Equity-based compensation expense 84,000,000.0 89,500,000
Deferred income taxes 42,000,000.0 18,500,000
Tax receivable agreement remeasurement (11,200,000) 900,000
Provision for bad debt expense 11,300,000 600,000
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable 4,400,000 26,800,000
Prepaid expenses and other current assets (11,000,000.0) (3,600,000)
Deferred costs and other assets, net of current portion (39,200,000) (38,500,000)
Income tax receivable (2,700,000) (1,200,000)
Accounts payable (12,700,000) 4,000,000.0
Accrued expenses and other liabilities (28,500,000) (22,700,000)
Unearned revenue 23,200,000 40,800,000
Net cash provided by operating activities 225,200,000 211,200,000
Cash flows from investing activities:    
Purchases of short-term investments (114,700,000) (15,200,000)
Maturities of short-term investments 94,300,000 20,600,000
Purchases of property and equipment and other assets (12,600,000) (14,800,000)
Cash paid for acquisitions, net of cash acquired 0 (143,600,000)
Net cash used in investing activities (33,000,000.0) (153,000,000.0)
Cash flows from financing activities:    
Payments of deferred consideration (400,000) (1,100,000)
Repayment of debt (3,000,000.0) 0
Payments of debt issuance and modification costs (2,700,000) (400,000)
Proceeds from exercise of stock options 400,000 600,000
Taxes paid related to net share settlement of equity awards (8,600,000) (7,600,000)
Proceeds from issuance of common stock under the employee stock purchase plan 4,400,000 0
Payments of equity issuance costs 0 (300,000)
Tax receivable agreement payments 0 (5,000,000)
Repurchase of common stock (87,000,000.0) 0
Net cash used in financing activities (96,900,000) (13,800,000)
Net increase (decrease) in cash, cash equivalents, and restricted cash 95,300,000 44,400,000
Cash, cash equivalents, and restricted cash at beginning of period 424,100,000 314,100,000
Cash, cash equivalents, and restricted cash at end of period 519,400,000 358,500,000
Cash, cash equivalents, and restricted cash at end of period:    
Cash and cash equivalents 509,700,000 352,700,000
Restricted cash, current 0 0
Restricted cash, non-current 9,700,000 5,800,000
Total cash, cash equivalents, and restricted cash 519,400,000 358,500,000
Supplemental disclosures of cash flow information    
Interest paid in cash 24,600,000 25,600,000
Cash paid for taxes 4,700,000 6,800,000
Supplemental disclosures of non-cash investing and financing activities:    
Deferred variable consideration from acquisition of a business 0 1,100,000
Property and equipment included in accounts payable and accrued expenses and other current liabilities 200,000 1,300,000
Equity-based compensation included in capitalized software $ 2,600,000 $ 0